Cargando…

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

OBJECTIVES: Yttrium-90 (Y90)-radioembolisation (RE) significantly regresses locally advanced hepatocellular carcinoma and delays disease progression. The current study is designed to deeply interrogate the immunological impact of Y90-RE, which elicits a sustained therapeutic response. DESIGN: Time-o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chew, Valerie, Lee, Yun Hua, Pan, Lu, Nasir, Nurul J M, Lim, Chun Jye, Chua, Camillus, Lai, Liyun, Hazirah, Sharifah Nur, Lim, Tony Kiat Hon, Goh, Brian K P, Chung, Alexander, Lo, Richard H G, Ng, David, Filarca, Rene L F, Albani, Salvatore, Chow, Pierce K H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352403/ https://www.ncbi.nlm.nih.gov/pubmed/29440463 http://dx.doi.org/10.1136/gutjnl-2017-315485

Ejemplares similares

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006)

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
por: Garnelo, Marta, et al.
Publicado: (2017)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021)

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel
por: Samim, Morsal, et al.
Publicado: (2017)

Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial
por: Vilgrain, Valérie, et al.
Publicado: (2014)

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
por: Chew, Valerie, et al.
Publicado: (2011)

Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
por: Lee, Boon Q, et al.
Publicado: (2019)

Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis
por: Nguyen, Nghia H, et al.
Publicado: (2016)

Comparison of the Biograph Vision and Biograph mCT for quantitative (90)Y PET/CT imaging for radioembolisation
por: Kunnen, Britt, et al.
Publicado: (2020)

Systemic Sclerosis Perturbs the Architecture of the Immunome
por: Paleja, Bhairav, et al.
Publicado: (2020)

Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy
por: KC, Mandip, et al.
Publicado: (2021)

Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis
por: Anugwom, Chimaobi, et al.
Publicado: (2023)

PHLDA3 overexpression in hepatocytes by endoplasmic reticulum stress via IRE1–Xbp1s pathway expedites liver injury
por: Han, Chang Yeob, et al.
Publicado: (2016)

Theranostic Imaging of Yttrium-90
por: Wright, Chadwick L., et al.
Publicado: (2015)

Radioembolisation in Europe: A Survey Amongst CIRSE Members
por: Reinders, Margot T. M., et al.
Publicado: (2018)

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
por: Welzel, Tania M, et al.
Publicado: (2017)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Public awareness and knowledge of liver health and diseases in Singapore
por: Tan, Chee‐Kiat, et al.
Publicado: (2021)

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care
por: Vu, Vinh D, et al.
Publicado: (2015)

Non-Target Activity Detection by Post-Radioembolization Yttrium-90 PET/CT: Image Assessment Technique and Case Examples
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Yttrium 90 Therapy: Is the Future Surgical?
por: Garlipp, Benjamin
Publicado: (2020)

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes
por: Mengshol, J A, et al.
Publicado: (2009)

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
por: Chan, Tim Hon Man, et al.
Publicado: (2014)

Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis
por: Lee, Sung Won, et al.
Publicado: (2020)

Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure
por: Kumar, Pavanish, et al.
Publicado: (2022)

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations
por: Gilman, Andrew J, et al.
Publicado: (2018)

STAT4-associated natural killer cell tolerance following liver transplantation
por: Jamil, K M, et al.
Publicado: (2017)

The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
por: Chen, Jianxiang, et al.
Publicado: (2016)

Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?
por: Tholey, Danielle M, et al.
Publicado: (2017)

Effect of COVID-19 on presentations of decompensated liver disease in Scotland
por: Manship, Thomas, et al.
Publicado: (2022)

Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infection
por: Keng, Choong Tat, et al.
Publicado: (2016)

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
por: Duseja, Ajay, et al.
Publicado: (2019)

Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis
por: Zhang, Bing, et al.
Publicado: (2015)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal
por: Leong, Jing Yao, et al.
Publicado: (2019)

Hyperbilirubinaemia in HIV–HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?
por: Kaspar, Matthew B, et al.
Publicado: (2016)

Mechanisms of liver disease in patients infected with HIV
por: Kaspar, Matthew B, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a66gf9kssndvi0ij91f2gdr4lt